CONSORT 2025 statement: updated guideline for reporting randomised trials

Hopewell, Sally; Chan, An-Wen; S Collins, Gary; Hróbjartsson, Asbjørn; Moher, David; F Schulz, Kenneth; Tunn, Ruth; Aggarwal, Rakesh; Berkwits, Michael; A Berlin, Jesse; Bhandari, Nita; J Butcher, Nancy; K Campbell, Marion; C W Chidebe, Runcie; Elbourne, Diana; Farmer, Andrew; A Fergusson, Dean; M Golub, Robert; N Goodman, Steven; C Hoffmann, Tammy; P A Ioannidis, John; C Kahan, Brennan; L Knowles, Rachel; E Lamb, Sarah; Lewis, Steff; Loder, Elizabeth; Offringa, Martin; Ravaud, Philippe; P Richards, Dawn; W Rockhold, Frank; L Schriger, David; L Siegfried, Nandi; Staniszewska, Sophie; S Taylor, Rod; Thabane, Lehana; Torgerson, David; Vohra, Sunita; R White, Ian; Boutron, Isabelle

doi:10.1136/bmj-2024-081123

Public

CONSORT 2025 statement: updated guideline for reporting randomised trials

Shared by NobleBlocks on Apr 14, 2025 • 12:00 AM UTC

Authors:

Sally Hopewell

An-Wen Chan

Gary S Collins

Abstract

Abstract Background Well designed and properly executed randomised trials are considered the most reliable evidence on the benefits of healthcare interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Tria...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!